24 Sep 2015

Turing pharmaceuticals backs down from dramatic price hike

From Morning Report, 8:39 am on 24 September 2015

The head of Turing pharmaceuticals has backed down from plans to dramatically raise the price of a 62-year-old drug used by AIDS patients. Peter Maybarduk works on public access to drugs issues with the "Public Citizen" lobby group in Washington, D.C.